Impact of glucocorticoid receptor gene polymorphisms on the metabolic profile of adult patients with the classical form of 21-hydroxylase deficiency.
<h4>Background</h4>CAH patients have an increased risk of cardiovascular disease, and it remains unknown if lifelong glucocorticoid (GC) treatment is a contributing factor. In the general population, glucocorticoid receptor gene (NR3C1) polymorphisms are associated with an adverse metabo...
Main Authors: | Ricardo P P Moreira, Larissa G Gomes, Berenice B Mendonca, Tânia A S S Bachega |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23028665/pdf/?tool=EBI |
Similar Items
-
Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
by: Ricardo P. P. Moreira, et al.
Published: (2011-01-01) -
Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency
by: Larissa G. Gomes, et al.
Published: (2013-01-01) -
The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene.
by: Vivian Oliveira Moura-Massari, et al.
Published: (2016-01-01) -
Comparison of different glucocorticoid regimens in the management of classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
by: T P Ajish, et al.
Published: (2014-01-01) -
Influence of the A3669G Glucocorticoid Receptor Gene Polymorphism on the Metabolic Profile of Pediatric Patients with Congenital Adrenal Hyperplasia
by: Ricardo P. P. Moreira, et al.
Published: (2014-01-01)